Publications by authors named "Kevin R Fox"

Claim this Profile
E
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.
Komal Jhaveri, Carey K Anders, Aditya Bardia, Manali Bhave, A Jo Chien, Kevin R Fox

Clin Breast Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Medication Taking Using a Wrist-Worn Commercially Available Wearable Device.
Amy I Laughlin, Quy Cao, Richard Bryson, Virginia Haughey, Rashad Abdul-Salaam, Kevin R Fox

JCO Clin Cancer Inform· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto, Amy S Clark, Robin Holmes, Kevin R Fox

NPJ Breast Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.
Maria K Pomponio, Laura Burkbauer, Macy Goldbach, Susanna M Nazarian, Fei Xie, Kevin R Fox

J Surg Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
Maria K Pomponio, Luke J Keele, Kevin R Fox, Amy S Clark, Jennifer M Matro

Breast Cancer Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer.
Amy S Clark, Nicholas P McAndrew, Andrea Troxel, Michael Feldman, Priti Lal, Kevin R Fox

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Jeffrey H Silber, Paul R Rosenbaum, Richard N Ross, Joseph G Reiter, Bijan A Niknam, Kevin R Fox

Milbank Q· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 DCIS Independent of Route: Results of Randomized Selection Design Trial.
Lea Lowenfeld, Rosemarie Mick, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Kevin R Fox

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Oncology Massage Into Chemoinfusion Suites: A Program Evaluation.
Jun J Mao, Karen E Wagner, Christina M Seluzicki, Audra Hugo, Laura K Galindez, Kevin R Fox

J Oncol Pract· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Thomas G Frazier, Kevin R Fox, J Stanley Smith, Christine Laronga, Anita McSwain

Pharmaceuticals (Basel)· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in colon cancer survival: a matched cohort study.
Jeffrey H Silber, Paul R Rosenbaum, Richard N Ross, Bijan A Niknam, Justin M Ludwig, Kevin R Fox

Ann Intern Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in breast cancer survival by race--reply.
Jeffrey H Silber, Paul R Rosenbaum, Kevin R Fox

JAMA· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics associated with differences in survival among black and white women with breast cancer.
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Kevin R Fox

JAMA· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.
Andrew J Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A Aqui, Kevin R Fox

Sci Transl Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 blockade: is combination therapy better than monotherapy?
Rebecca L Hirsh, Kevin R Fox

Curr Treat Options Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of chemotherapy for early stage breast cancer: have we reached the limit? What is the survival impact of amenorrhea?
Rebecca L Hirsh, Kevin R Fox

Curr Treat Options Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for lymphedema after breast cancer treatment.
Sandra A Norman, A Russell Localio, Michael J Kallan, Anita L Weber, Heather A Simoes Torpey, Kevin R Fox

Cancer Epidemiol Biomarkers Prev· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding zoledronic acid to endocrine therapy in the adjuvant treatment of hormone-sensitive breast cancer in premenopausal women: a new care standard or a provocative idea?
Kevin R Fox

Curr Oncol Rep· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micrometastases in axillary sentinel lymph nodes: how significant are they?
Kevin R Fox

Curr Oncol Rep· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer.
Robert E Roses, E Carter Paulson, Anupama Sharma, Jeanne E Schueller, Harvey Nisenbaum, Kevin R Fox

Cancer Epidemiol Biomarkers Prev· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing outcomes with bevacizumab by better targeting patients and tumors.
Angela DeMichele, Kevin R Fox

Oncology (Williston Park)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Techniques for fertility preservation in patients with breast cancer.
Lara Dunn, Kevin R Fox

Curr Opin Obstet Gynecol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer.
Kevin R Fox

Curr Oncol Rep· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing adjuvant letrozole to patients well after the completion of tamoxifen: a good idea?
Kevin R Fox

Curr Oncol Rep· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of MRI scanning of the contralateral breast in women with newly diagnosed breast cancer: a new care standard or not?
Kevin R Fox

Curr Oncol Rep· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis